Johnson & Johnson
USUSDJohnson & Johnson (MX:JNJ) — Biotechnology: Pharmaceutical Preparations. Numero di borse in cui sono quotate le azioni della società: 3. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- jnj.com
- Relazioni con gli Investitori
- investor.jnj.com/overview/default.aspx
- Settore
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Centrale
- New Brunswick, United States
- Amministratore Delegato
- Joaquin Duato
- Dipendenti
- 136 400
- Fondata
- 1886
- Quotata dal
- 29.05.2003 (MX:JNJ)
- Azioni in Circolazione
- Flottante
- 2.41 Mld
- Capitalizzazione di Mercato
- 655.37 Mld USD
- Insider
- 0.05%
- Investitori Istituzionali
- 76.73%
- Settore (SIC)
- Pharmaceutical Preparations
- Forma Giuridica
- XSNP
- ISIN
- US4781601046
- LEI
- 549300G0CFPGEF6X2043
- P/E
- 30.9
- Payout Ratio
- 60.0%
- FCF
- 22.2 Mld USD
- Pagamenti / FCF
- 57%
- Debito
- 49.0 Mld USD1.3 anni di FCF
- Serie di Dividendi
- 56+ a.
- Utili, FCF e dividendi pagati — per i 12 mesi fino a 28.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dividendi
Johnson & Johnson (JNJ) paga dividendi trimestralmente. All'anno (12 mesi fino all'ultimo pagamento annunciato): 96.0094 MXN per azione (pagamenti: 4). Questo rappresenta circa il 2.00% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 24.11.2026. Storia dei dividendi ininterrotta: 56 anni.
| Data Ex | Pagamento | Importo | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-08-25 | — | 24.3660 MXN | 0.5/2.1 % | trimestrale | MX:JNJ |
| 2026-05-26 | — | 24.3660 MXN | 0.6/2.4 % | trimestrale | MX:JNJ |
| 2026-02-24 | — | 23.6387 MXN | 0.6/2.2 % | trimestrale | MX:JNJ |
| 2025-11-25 | — | 23.6387 MXN | 0.6/2.5 % | trimestrale | MX:JNJ |
| 2025-08-26 | — | 23.6387 MXN | 0.7/2.8 % | trimestrale | MX:JNJ |
| 2025-05-27 | — | 23.6387 MXN | 0.8/3.1 % | trimestrale | MX:JNJ |
| 2025-02-18 | — | 22.5477 MXN | 0.7/2.8 % | trimestrale | MX:JNJ |
| 2024-11-26 | — | 22.5477 MXN | 0.7/2.8 % | trimestrale | MX:JNJ |
| 2024-08-27 | — | 22.5477 MXN | 0.7/2.8 % | trimestrale | MX:JNJ |
| 2024-05-20 | — | 22.5477 MXN | 0.9/3.4 % | trimestrale | MX:JNJ |
| 2024-02-16 | — | 21.6385 MXN | 0.8/3.2 % | trimestrale | MX:JNJ |
| 2023-11-21 | — | 21.6385 MXN | 0.8/3.3 % | trimestrale | MX:JNJ |
| 2023-08-25 | — | 21.6385 MXN | 0.8/3.0 % | trimestrale | MX:JNJ |
| 2023-05-22 | — | 21.6385 MXN | 0.8/3.0 % | trimestrale | MX:JNJ |
| 2023-02-17 | — | 20.5475 MXN | 0.7/2.8 % | trimestrale | MX:JNJ |
| 2022-11-22 | — | 20.5475 MXN | 0.6/2.4 % | trimestrale | MX:JNJ |
| 2022-08-22 | — | 20.5475 MXN | 0.6/2.3 % | trimestrale | MX:JNJ |
| 2022-05-23 | — | 20.5475 MXN | 0.6/1.7 % | trimestrale | MX:JNJ |
| 2022-02-18 | — | 19.2746 MXN | 0.6/1.1 % | trimestrale | MX:JNJ |
| 2021-11-22 | — | 19.2746 MXN | 0.6/0.6 % | trimestrale | MX:JNJ |
Notizie di Questa Settimana
Comunicati stampa dal sito web per investitori della società, aggiornati quotidianamente. I link conducono al sito web dell'azienda. I titoli sono nella lingua originale, come sul sito web dell'azienda.
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| BlackRock | 8.8% | 212.1 Mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.52% | 157.23 Mln | 2026-06-30 |
| State Street Corporation | 5.55% | 133.78 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.17% | 76.42 Mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.67% | 64.37 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 62.38 Mln | 2026-06-30 |
| Geode Capital Management… | 2.45% | 59.09 Mln | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.42% | 58.3 Mln | 2026-06-30 |
| Morgan Stanley | 1.86% | 44.81 Mln | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 32.48 Mln | 2026-07-31 |
| NORGES BANK | 1.32% | 31.83 Mln | 2026-06-30 |
| State Farm Mutual Automo… | 1.31% | 31.59 Mln | 2026-06-30 |
| Fidelity Concord Street… | 1.29% | 31.13 Mln | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 29.45 Mln | 2026-08-31 |
| Northern Trust Corporati… | 1.19% | 28.79 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 22.91 Mln | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.3 Mln | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 13.53 Mln | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 13.07 Mln | 2026-06-30 |
| VANGUARD WHITEHALL FUNDS… | 0.39% | 9.48 Mln | 2026-04-30 |
| DUATO JOAQUIN BOIX (Chie… | ≈0.01% | 307 837 | 2026-08-13 |
| TAUBERT JENNIFER L (Offi… | ≈0.01% | 194 451 | 2026-08-17 |
| WENGEL KATHRYN E (Chief… | ≈0% | 114 659 | 2026-06-11 |
| WOLK JOSEPH J (Chief Fin… | ≈0% | 85 008 | 2026-02-17 |
| SCHMID TIMOTHY (Officer) | ≈0% | 26 251 | 2026-09-02 |
| SWANSON JAMES D (Chief T… | ≈0% | 25 698 | 2026-02-17 |
| REED JOHN C (Officer) | ≈0% | 24 911 | 2026-05-01 |
| DECKER ROBERT J (Officer… | ≈0% | 24 462 | 2026-02-27 |
| BROADHURST VANESSA (Offi… | ≈0% | 23 003 | 2026-07-20 |
| MULHOLLAND KRISTEN (Offi… | ≈0% | 19 830 | 2026-02-13 |
| The Vanguard Group | — | — | — |
